- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease(COPD) in Norway
Total 870 results
-
Norwegian University of Science and TechnologyCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Helse Stavanger HFCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Lovisenberg Diakonale HospitalUniversity of Oslo; University of Bergen; Norwegian Foundation for Health and...Completed
-
Norwegian University of Science and TechnologyCompletedChronic Obstructive Pulmonary Disease | COPDNorway
-
Western Norway University of Applied SciencesRecruitingCOPD Chronic Obstructive Pulmonary DiseaseNorway
-
University Hospital, AkershusAstraZeneca; Haukeland University HospitalCompletedEffect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease (RODEO)Chronic Obstructive Pulmonary Disease (COPD)Norway
-
Haukeland University HospitalWestern Norway University of Applied Sciences; Norwegian Fund for Postgraduate...Active, not recruiting
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, Denmark, Finland, Netherlands, Norway
-
University of Southern DenmarkUniversity of Oslo; Lund UniversityCompletedCardiovascular Diseases | Chronic Obstructive Pulmonary Disease (COPD) | Type-2 DiabetesDenmark, Norway, Sweden
-
Lovisenberg Diakonale HospitalUniversity of Oslo; Norwegian Extra Foundation for Health and RehabilitationCompletedChronic Obstructive Pulmonary DiseaseNorway
-
Norwegian University of Science and TechnologyHelse Nord-Trøndelag HFCompletedChronic Obstructive Pulmonary DiseaseNorway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, Estonia, Hungary, Belgium, Czech Republic, Norway, Korea, Republic of, Lithuania
-
Ullevaal University HospitalCompleted
-
LHL HelseCompletedChronic Obstructive Pulmonary DiseaseNorway
-
LHL HelseKarolinska Institutet; Lovisenberg Diakonale HospitalCompletedChronic Obstructive Pulmonary DiseaseNorway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease, COPDPoland, United States
-
LHL HelseCompletedChronic Obstructive Pulmonary Disease | AsthmaNorway
-
Molde University CollegeNot yet recruitingChronic Obstructive Pulmonary DiseaseNorway
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
LHL HelseCompletedChronic Obstructive Pulmonary Disease | HypoxemiaNorway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
Hofseth Biocare ASAMøre og Romsdal Hospital TrustNot yet recruitingChronic Obstructive Pulmonary DiseaseNorway
-
Norwegian University of Science and TechnologyHelse Nord-Trøndelag HF; Nord-Trøndelag University CollegeCompletedChronic Obstructive Pulmonary DiseaseNorway
-
Inland Norway University of Applied SciencesUniversity of Copenhagen; University of Bergen; Sykehuset Innlandet HF; Norwegian... and other collaboratorsCompletedChronic Obstructive Pulmonary DiseaseNorway
-
LHL HelseCompletedHypoxia | Chronic Obstructive Pulmonary DiseaseNorway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseSweden, Denmark, Norway
-
Oslo University HospitalUniversity of California, San FranciscoCompletedChronic Obstructive Pulmonary DiseaseNorway
-
Sykehuset Innlandet HFCompletedChronic Obstructive Pulmonary Disease | Pulmonary EmbolismNorway
-
Pearl Therapeutics, Inc.Completed
-
University of BergenCompletedDepression | Chronic Obstructive Pulmonary Disease | AnxietyNorway
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Canada, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
NovartisCompletedCOPDUnited States, Argentina, Germany, Spain, Canada, India, Turkey, Sweden, Italy
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, France, Italy, Spain, Turkey, United Kingdom, Germany, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Greece, Ireland, Switzerland
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
Norwegian University of Science and TechnologyUniversity of Copenhagen; Haukeland University Hospital; St. Olavs HospitalCompletedPulmonary Disease, Chronic ObstructiveNorway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Germany, Spain, Turkey, Hungary, Czech Republic, India, Slovakia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD) With CachexiaUnited States, United Kingdom, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSweden, Norway
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseDenmark, Finland, Norway, Netherlands
-
Norwegian University of Science and TechnologyCompletedCardiovascular Disease | Chronic Obstructive Pulmonary DiseaseNorway
-
Oslo University CollegeOslo University Hospital; Hospital Pharmacy Enterprise, South Eastern NorwayCompletedPulmonary Disease, Chronic ObstructiveNorway
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHypoxia | Pulmonary Disease, Chronic Obstructive | Hypertension, PulmonaryNorway
-
Assuta Medical CenterNorwegian Centre for Integrated Care and Telemedicine (NST); Open-Evidence... and other collaboratorsUnknownDiabetes Mellitus | Chronic Obstructive Pulmonary Disease | Chronic Heart Failure | Special Orthopaedic Co-Morbidity After Hip/Knee ReplacementIsrael, Norway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Ostfold Hospital TrustSt. Olavs HospitalCompletedChronic Obstructive Pulmonary Disease | Urinary IncontinenceNorway